Bristol-Myers Squibb
Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMY
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.
BMY Key Statistics
Stock Snapshot
With a market cap of 126.99B, Bristol-Myers Squibb(BMY) trades at $62.37. The stock has a price-to-earnings ratio of 17.66 and currently yields dividends of 4.1%.
As of 2026-02-27, Bristol-Myers Squibb(BMY) stock has fluctuated between $60.80 and $62.68. The current price stands at $62.37, placing the stock +2.6% above today's low and -0.5% off the high.
The Bristol-Myers Squibb(BMY)'s current trading volume is 16.88M, compared to an average daily volume of 12.12M.
In the last year, Bristol-Myers Squibb(BMY) shares hit a 52-week high of $63.33 and a 52-week low of $42.52.
In the last year, Bristol-Myers Squibb(BMY) shares hit a 52-week high of $63.33 and a 52-week low of $42.52.
BMY News
Bristol Myers Squibb (NYSE:BMY) reported positive Phase 2 results for Reblozyl in treating anemia in alpha thalassemia patients. The company announced FDA acce...
If you are wondering whether Bristol-Myers Squibb is offering good value at today’s price, you are not alone. This article is built to help you frame that quest...
Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study. The Bristol-Myers Squibb (BMY) study “A Phase 1/2 Study of the Safety,...
Analyst ratings
59%
of 32 ratingsMore BMY News
Bristol-Myers Squibb & Co. (NYSE:BMY) on Monday released topline results from a phase 2 study evaluating Reblozyl for anemia in adults with Alpha (α)-Thalassemi...
Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study. The new Bristol-Myers Squibb study, “A Phase 1/2a, Open-label, First-in...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.